212 related articles for article (PubMed ID: 22221908)
21. Calcinosis cutis: part II. Treatment options.
Reiter N; El-Shabrawi L; Leinweber B; Berghold A; Aberer E
J Am Acad Dermatol; 2011 Jul; 65(1):15-22; quiz 23-4. PubMed ID: 21679811
[TBL] [Abstract][Full Text] [Related]
22. Idiopathic calcific pancreatitis, CRST syndrome and progressive systemic sclerosis.
Greif JM; Wolff WI
Am J Gastroenterol; 1979 Feb; 71(2):177-82. PubMed ID: 433900
[TBL] [Abstract][Full Text] [Related]
23. Systemic sclerosis sine scleroderma and calcinosis cutis: report of a rare case.
Sharma NL; Mahajan VK; Ranjan N; Sharma VC; Gupta M
Clin Rheumatol; 2010 Feb; 29(2):215-9. PubMed ID: 19834761
[TBL] [Abstract][Full Text] [Related]
24. Effects of rituximab therapy on elastic properties of vascular wall in patients with progressive systemic sclerosis.
Maslyanskiy AL; Lapin SV; Kolesova EP; Penin IN; Cheshuina MD; Feist E; Konradi AO
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-228. PubMed ID: 24480389
[No Abstract] [Full Text] [Related]
25. Treatment of cutaneous calcinosis in CREST syndrome by extracorporeal shock wave lithotripsy.
Sparsa A; Lesaux N; Kessler E; Bonnetblanc JM; Blaise S; Lebrun-Ly V; Colombeau P; Vidal E; Bédane C
J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S263-5. PubMed ID: 16227105
[TBL] [Abstract][Full Text] [Related]
26. Response of dystrophic calcification to intravenous immunoglobulin.
Schanz S; Ulmer A; Fierlbeck G
Arch Dermatol; 2008 May; 144(5):585-7. PubMed ID: 18490584
[No Abstract] [Full Text] [Related]
27. Rituximab in diffuse cutaneous systemic sclerosis: should we be using it today?
McQueen FM; Solanki K
Rheumatology (Oxford); 2015 May; 54(5):757-67. PubMed ID: 25573841
[TBL] [Abstract][Full Text] [Related]
28. CRST syndrome with persistent gastrointestinal bleeding. (Calcinosis, raynaud's phenomenon, sclerodactyly and telangiectasia).
Kolodny M; Baker WG
Gastrointest Endosc; 1968 Aug; 15(1):16-7. PubMed ID: 5302707
[No Abstract] [Full Text] [Related]
29. Treatment of cutaneous calcinosis in limited systemic sclerosis with minocycline.
Robertson LP; Marshall RW; Hickling P
Ann Rheum Dis; 2003 Mar; 62(3):267-9. PubMed ID: 12594118
[TBL] [Abstract][Full Text] [Related]
30. Calcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78 patients, 1996-2009.
Balin SJ; Wetter DA; Andersen LK; Davis MD
Arch Dermatol; 2012 Apr; 148(4):455-62. PubMed ID: 22184719
[TBL] [Abstract][Full Text] [Related]
31. Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: A review of the literature.
Traineau H; Aggarwal R; Monfort JB; Senet P; Oddis CV; Chizzolini C; Barbaud A; Francès C; Arnaud L; Chasset F
J Am Acad Dermatol; 2020 Feb; 82(2):317-325. PubMed ID: 31302187
[TBL] [Abstract][Full Text] [Related]
32. Telangiectasis in CREST syndrome and systemic sclerosis: correlation of clinical and pathological features with response to pulsed dye laser treatment.
Halachmi S; Gabari O; Cohen S; Koren R; Amitai DB; Lapidoth M
Lasers Med Sci; 2014 Jan; 29(1):137-40. PubMed ID: 23494102
[TBL] [Abstract][Full Text] [Related]
33. Are there risk factors for scleroderma-related calcinosis?
Pai S; Hsu V
Mod Rheumatol; 2018 May; 28(3):518-522. PubMed ID: 28722530
[TBL] [Abstract][Full Text] [Related]
34. Scleroderma with type III glomerulonephritis and MPO-ANCA antibodies in the serum.
Herrera-Esparza R; Aguilar JL; Saucedo A; González I; López-Robles E; Avalos-Díaz E
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):617-20. PubMed ID: 16164722
[TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin for treatment of Raynaud phenomenon in CREST syndrome.
Berk-Krauss J; Christman MP; Franks A; Sicco KL; Liebman TN
Dermatol Online J; 2018 Dec; 24(12):. PubMed ID: 30677800
[TBL] [Abstract][Full Text] [Related]
36. Increased bone resorption and failure to respond to antiresorptive therapy in progressive dystrophic calcification.
Murphy E; Freaney R; Bresnihan B; McKenna M; FitzGerald O
Calcif Tissue Int; 2003 Nov; 73(5):433-40. PubMed ID: 12958696
[TBL] [Abstract][Full Text] [Related]
37. Calcinosis: pathophysiology and management.
Valenzuela A; Chung L
Curr Opin Rheumatol; 2015 Nov; 27(6):542-8. PubMed ID: 26352733
[TBL] [Abstract][Full Text] [Related]
38. Successful palliation and significant remission of cutaneous calcinosis in CREST syndrome with carbon dioxide laser.
Chamberlain AJ; Walker NP
Dermatol Surg; 2003 Sep; 29(9):968-70. PubMed ID: 12930342
[TBL] [Abstract][Full Text] [Related]
39. [Successful treatment of toe gangrene with moderate-dose steroid therapy in a patient with systemic sclerosis (CREST syndrome)].
Yamada S; Kameda H; Hirakata M; Ohosone Y; Mimori T; Ikeda Y
Ryumachi; 1997 Jun; 37(3):499-503. PubMed ID: 9256035
[TBL] [Abstract][Full Text] [Related]
40. Calcinosis in rheumatic diseases.
Boulman N; Slobodin G; Rozenbaum M; Rosner I
Semin Arthritis Rheum; 2005 Jun; 34(6):805-12. PubMed ID: 15942915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
